- Home
- CRDF vs OPFI Comparison
CRDF vs OPFI Comparison
Compare CRDF & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- OPFI
- Stock Information
- Founded
- CRDF 1999
- OPFI 2009
- Country
- CRDF United States
- OPFI United States
- Employees
- CRDF N/A
- OPFI N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- OPFI Finance: Consumer Services
- Sector
- CRDF Health Care
- OPFI Finance
- Exchange
- CRDF Nasdaq
- OPFI Nasdaq
- Market Cap
- CRDF 144.4M
- OPFI 300.3M
- IPO Year
- CRDF N/A
- OPFI N/A
- Fundamental
- Price
- CRDF $2.04
- OPFI $11.15
- Analyst Decision
- CRDF Strong Buy
- OPFI Buy
- Analyst Count
- CRDF 5
- OPFI 2
- Target Price
- CRDF $11.10
- OPFI $11.75
- AVG Volume (30 Days)
- CRDF 1.1M
- OPFI 970.2K
- Earning Date
- CRDF 11-06-2025
- OPFI 11-06-2025
- Dividend Yield
- CRDF N/A
- OPFI 9.00%
- EPS Growth
- CRDF N/A
- OPFI N/A
- EPS
- CRDF N/A
- OPFI N/A
- Revenue
- CRDF $545,000.00
- OPFI $320,831,000.00
- Revenue This Year
- CRDF N/A
- OPFI $116.69
- Revenue Next Year
- CRDF N/A
- OPFI $9.90
- P/E Ratio
- CRDF N/A
- OPFI N/A
- Revenue Growth
- CRDF N/A
- OPFI 31.26
- 52 Week Low
- CRDF $1.90
- OPFI $4.16
- 52 Week High
- CRDF $5.64
- OPFI $17.73
- Technical
- Relative Strength Index (RSI)
- CRDF 36.16
- OPFI 58.83
- Support Level
- CRDF $2.03
- OPFI $10.03
- Resistance Level
- CRDF $2.27
- OPFI $10.59
- Average True Range (ATR)
- CRDF 0.12
- OPFI 0.42
- MACD
- CRDF 0.04
- OPFI 0.15
- Stochastic Oscillator
- CRDF 37.84
- OPFI 96.88
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.